Xerient Overview
Xerient is focused on unmet needs in cancer treatment, particularly in abdominal and gastrointestinal cancers. Xerient is pursuing the development of novel therapeutics and diagnostic technologies that can dramatically improve the survival of these patients. The company is introducing a portfolio of products that will address hard to treat cancers in the abdominal/GI area, beginning with solutions for pancreatic cancer.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $5.03M |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 3 |
| Investors | 2 |
Team Members
1
Employees: 1-10
Web & Social Links
| Website | xerient.net/ |
Locations
Petah Tikva, Israel
Photos & Videos
No files yet
Xerient Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
—Tags (4)
gastroenterologycancerpharmaceuticalscancer-therapyXerient Financials
Xerient Lifecycle
Xerient News
0 articlesNo news articles.
Xerient Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 1 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 6 classification IDs that could be used for matching.
Xerient Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 80/100 |
| Missing | sector, video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516031630 |
| Creator | Amit Alfasi |
| Creator email | amit@peregrinevc.com |
| Last update | 2024-03-07T00:00:00.000Z |
| Created | 2024-03-07T00:00:00.000Z |